Home › NDC Lookup › Ingredients › Magnesium Sulfate › 11673-0602-01
Epsom Salt Magnesium Sulfate 1 g/g Granule, For Solution, 1814 g — NDC 11673-0602-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Epsom Salt Magnesium Sulfate 1 g/g Granule, For Solution, 1814 g — NDC 11673-602-01 (Billing 11673-0602-01)

by Target Corporation · 1814 g in 1 POUCH

This is a package of 1,814 g of Epsom Salt Magnesium Sulfate 1 g/g Granule, For Solution from Target Corporation, no longer marketed (first marketed Dec 1996), no longer in the FDA NDC Directory. It is the main listing for this product, which comes in 3 package sizes.

NDC 11673-0602-01
🏷️ FDA NDC (as labeled) 11673-602-01 billing pads the product segment with a zero
This package
Contains1814 g Pack sizes3 compare ↓
Main listing for product 11673-602 · Also comes in: 1814 g 11673-602-07 3630 g 11673-602-80
OTC Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 11673-602-01
Product NDC 11673-602
11-digit billing NDC 11673060201
RxCUI 1053346
UNII SK47B8698T
Application # M007
SPL Set ID 87f98e6c-a3a1-4ca5-bd56-977e38f48914
Established class (EPC) Calculi Dissolution Agent; Osmotic Activity
Mechanism of action Magnesium Ion Exchange Activity
Physiologic effect Increased Large Intestinal Motility; Inhibition Large Intestine Fluid/Electrolyte Absorption; Inhibition Small Intestine Fluid/Electrolyte Absorption
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Discontinued by firm
Marketing start 1996-12-12
Route ORAL, TOPICAL
Dosage form GRANULE, FOR SOLUTION
Substance MAGNESIUM SULFATE HEPTAHYDRATE
Quick answers
  • RxCUI (RxNorm): 1053346
Why two NDCs? The FDA registers this code as 11673-602-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 11673-0602-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Osmotically acting laxatives class.

Drug family (ATC) Osmotically acting laxatives, Magnesium, Electrolyte solutions
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. The IV injection is used in hospitals to prevent and control seizures in preeclampsia and eclampsia. Epsom salt products by mouth are for occasional cons...
  • Follow your package directions. They generally say to dissolve the dose in a full glass of water and then drink more liquid. It usually works in about 30 minutes to 6 hours. Don't...
  • How do I take Epsom salt for constipation?
  • Flushing, sweating, low blood pressure, and drowsiness are common. Your team also checks your reflexes, breathing and magnesium levels to catch problems early.
📖 Read our full Magnesium Sulfate guide →
6
Nutrient depletion considerations

Magnesium Sulfate (prescription drug) may be associated with lower levels of 6 nutrients — worth a chat with your pharmacist, not a cause for alarm.

An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 1814 g 3630 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
11673-0602-01 You're viewing this Main listing 1814 g in 1 POUCH 1996-12-12 — Discontinued by firm
11673-0602-07 11673-602-07 1814 g in 1 POUCH 1996-12-12 — Active
11673-0602-80 11673-602-80 3630 g in 1 POUCH 2026-09-04 — Active

Pack size FAQ

What quantity is in this package?
This package contains 1814 g — 1814 g in 1 pouch.
How does this package differ from NDC 11673-0602-07?
Both are Epsom Salt Magnesium Sulfate 1 g/g Granule, For Solution — the drug itself is identical. This page's package is the 1814 g one, while NDC 11673-0602-07 is the 1814 g package.
What NDC number is used to bill for this package of Epsom Salt Magnesium Sulfate 1 g/g Granule, For Solution?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Epsom Salt 1 g/g 36800-0602-07 Topco 1814 g — — FDA listed —
Epsom Salt 1 g/g 53943-0602-07 Discount 1814 g — — FDA listed —
365 Whole Foods Market Epsom Salt 1 g/g 42681-0060-01 Whole 1814 g — — FDA listed —
Epsom Salt 1 g/g 55910-0038-07 Old 1814 g — — FDA listed —
Epsom Salt 1 g/g 63941-0602-07 Valu 1814 g — — FDA listed —
Epsom Salt 1 g/g 11673-0200-45 Target 1800 g — — FDA listed —
Epsom Salt 1 g/g 21130-0602-01 Safeway 1814 g — — Discontinued —
Epsom Salt 1 g/g 42507-0962-06 Hy-Vee, 454 g — — FDA listed —
Epsom Salt 1 g/g 72476-0602-04 Retail 1814 g — — FDA listed —
Epsom Salt 1 g/g 76162-0029-80 Topco 3630 g — — FDA listed —
Epsom Salt 1 g/g 41163-0602-07 United 1814 g — — FDA listed —
Epsom Salt 1 g/g 72288-0602-04 Amazon.com 2720 g — — Discontinued —
Epsom Salt 1 g/g 83324-0175-04 Chain 1814 g — — FDA listed —
Epsom Salt 1 g/g 85828-0602-07 Grocery 1814 g — — FDA listed —
Epsom Salt 1 g/g 55301-0602-07 Your 1814 g — — FDA listed —
Epsom Salt 1 g/g 41250-0602-07 Meijer, 1814 g — — FDA listed —
Epsom Salt 1 g/g 72036-0602-01 HARRIS 1814 g — — FDA listed —
Epsom Salt 1 g/g 00869-0602-10 Vi-Jon, 1814 g — — FDA listed —
Epsom Salt 1 g/g 00363-0942-05 Walgreen 2721 g — — Discontinued —
Epsom Salt 1 g/gthis 11673-0602-01 Target 1814 g — — Discontinued —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1996
On the market since
Dec 1996
📍
2026
Currently FDA-listed
30 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

From the label’s inactive-ingredient sectionNone

This is label-wide narrative text, not a normalized exact-product ingredient list. A label can cover multiple strengths or packages.

Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerTarget Corporation
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code11673
First marketedDec 1996
Product typeHuman Otc Drug
Portfolio409 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 18 words ▾

Uses for relief of occasional constipation (irregularity) this product generally produces bowel movement in 1/2 to 6 hours

⏱️ Dosage and Administration 90 words ▾

Directions do not exceed recommended daily dosage drink a full glass (8 ounces) of liquid with each dose may be taken as a single daily dose or in divided doses dissolve the dose in 8 ounces of water. Lemon juice may be added to improve the taste adults and children 12 years and over - 2 to 6 level teaspoons (10 to 30 grams) daily children 6 to under 12 years - 1 to 2 level teaspoons (5 to 10 grams) daily children under 6 years - consult a doctor

⚠️ Warnings 1 words ▾

Warnings

🤒 Adverse Reactions 34 words ▾

Adverse Reaction Satisfaction guaranteed - Love it or your money back. We welcome any questions you may have at Target.com/comments or 1-800-910-6874. Distributed by Target Corporation Minneapolis, MN 55403 TM & ©2026 TargetBrands, Inc.

🧪 Active Ingredient 7 words ▾

Active ingredient Magnesium sulfate USP (Heptahydrate) 100%

🧪 Inactive Ingredients 3 words ▾

inactive ingredient None

🎯 Purpose 3 words ▾

Purpose Saline laxative

📄 Ask a Doctor Before Use If 41 words ▾

Ask a Doctor before use kidney disease a magnesium-restricted diet abdominal pail, nausea or vomiting noticed a sudden change in bowel habits that persists over a period of 2 weeks already used a laxative for a period longer than 1 week.

📄 Ask a Doctor or Pharmacist Before Use If 33 words ▾

Ask a doctor or pharmacist before use if you are taking any other drug. Take this product 2 or more hours before or after other drugs. Laxatives may affect how other drugs work.

📄 Stop Use and Ask a Doctor If 28 words ▾

Stop use and ask a doctor if you have rectal bleeding or failure to have a bowel movement after use. These could be signs of a serious condition.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Other Information 12 words ▾

Other information Other information magnesium content 495 mg per teaspoon (5 grams)

📄 Questions or Comments 3 words ▾

Questions? Call 1-800-910-6874

📄 Package Label / Principal Display Panel 43 words ▾

Principal Display Panel RECLOSABLE BAG / TEAR HERE TO OPEN NDC 11673-602-80 Epsom Salt Magnesium Sulfat USP Saline Laxative up&up™ Saline Laxative for Relief of Occasional Constipation Soaking Solution Helps Ease Sore and Tired Muscles NET WT 8 LB (3.63 kg) mm01 mm02

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Magnesium Sulfate (matched by generic name) — the program that covers self-administered drugs. 5 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Magnesium Sulfate. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$64.1K
Claims incl. refills
2.6K
Beneficiaries
506
Spend / beneficiary
$126.60
Spend / claim
$24.56
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 1814 g (11673-0602-07), 3630 g (11673-0602-80). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Target Corporation is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.